News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,254 Results
Type
Article (60504)
Company Profile (198)
Press Release (635537)
Multimedia
Podcasts (169)
Webinars (25)
Section
Business (179779)
Career Advice (2794)
Deals (33480)
Drug Delivery (153)
Drug Development (76868)
Employer Resources (175)
FDA (17429)
Job Trends (15155)
News (318469)
Policy (35444)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2877)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (160)
Alliances (46410)
ALS (183)
Alzheimer's disease (1802)
Antibody-drug conjugate (ADC) (365)
Approvals (17620)
Artificial intelligence (616)
Autoimmune disease (195)
Automation (43)
Bankruptcy (345)
Best Places to Work (11847)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (115)
Bladder cancer (172)
Brain cancer (65)
Breast cancer (662)
Cancer (5099)
Cardiovascular disease (469)
Career advice (2380)
Career pathing (43)
CAR-T (290)
CDC (68)
Celiac Disease (1)
Cell therapy (798)
Cervical cancer (41)
Clinical research (66037)
Collaboration (1823)
Company closure (5)
Compensation (1224)
Complete response letters (83)
COVID-19 (2953)
CRISPR (107)
C-suite (933)
Cystic fibrosis (153)
Data (6474)
Decentralized trials (2)
Denatured (49)
Depression (166)
Diabetes (533)
Diagnostics (6902)
Digital health (53)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (275)
Drug pricing (229)
Drug shortages (34)
Duchenne muscular dystrophy (258)
Earnings (72003)
Editorial (69)
Employer branding (21)
Employer resources (156)
Events (112828)
Executive appointments (1034)
FDA (20750)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (24)
Funding (1560)
Gene editing (224)
Generative AI (54)
Gene therapy (667)
GLP-1 (1124)
Government (5420)
Grass and pollen (8)
Guidances (388)
Healthcare (19935)
HIV (73)
Huntington's disease (56)
IgA nephropathy (89)
Immunology and inflammation (305)
Immuno-oncology (75)
Indications (134)
Infectious disease (3272)
Inflammatory bowel disease (210)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (256)
Interviews (516)
IPO (15748)
IRA (61)
Job creations (3656)
Job search strategy (1956)
JPM (72)
Kidney cancer (19)
Labor market (88)
Layoffs (635)
Leadership (44)
Legal (8280)
Liver cancer (99)
Longevity (21)
Lung cancer (670)
Lymphoma (385)
Machine learning (47)
Management (60)
Manufacturing (854)
MASH (181)
Medical device (13976)
Medtech (14042)
Mergers & acquisitions (18864)
Metabolic disorders (1443)
mRNA (194)
Multiple sclerosis (172)
NASH (23)
Neurodegenerative disease (376)
Neuropsychiatric disorders (108)
Neuroscience (3181)
Neurotech (1)
NextGen: Class of 2026 (6953)
Non-profit (4849)
Now hiring (50)
Obesity (717)
Opinion (333)
Ovarian cancer (167)
Pain (223)
Pancreatic cancer (243)
Parkinson's disease (307)
Partnered (32)
Patents (533)
Patient recruitment (536)
Peanut (60)
People (55703)
Pharmaceutical (50)
Pharmacy benefit managers (34)
Phase 1 (20325)
Phase 2 (28439)
Phase 3 (22520)
Pipeline (6092)
Policy (357)
Postmarket research (2693)
Preclinical (8186)
Press Release (64)
Prostate cancer (271)
Psychedelics (61)
Radiopharmaceuticals (292)
Rare diseases (1007)
Real estate (5606)
Recruiting (72)
Regulatory (26696)
Reports (46)
Research institute (2609)
Resumes & cover letters (446)
Rett syndrome (31)
RNA editing (17)
RSV (91)
Schizophrenia (164)
Series A (263)
Series B (198)
Service/supplier (10)
Sickle cell disease (106)
Special edition (27)
Spinal muscular atrophy (162)
Sponsored (48)
Startups (3510)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (101)
The Weekly (119)
Vaccines (1176)
Venture capital (103)
Weight loss (487)
Women's health (105)
Worklife (23)
Date
Today (53)
Last 7 days (707)
Last 30 days (2889)
Last 365 days (30725)
2026 (5794)
2025 (31062)
2024 (35275)
2023 (39762)
2022 (50901)
2021 (55536)
2020 (54476)
2019 (47617)
2018 (36147)
2017 (32561)
2016 (32365)
2015 (36456)
2014 (29314)
2013 (24422)
2012 (26173)
2011 (26712)
2010 (24328)
Location
Africa (953)
Alabama (84)
Alaska (7)
Arizona (289)
Arkansas (13)
Asia (40239)
Australia (7109)
California (11652)
Canada (3259)
China (1108)
Colorado (474)
Connecticut (520)
Delaware (346)
Europe (95545)
Florida (1763)
Georgia (391)
Hawaii (4)
Idaho (54)
Illinois (926)
India (77)
Indiana (557)
Iowa (23)
Japan (462)
Kansas (128)
Kentucky (40)
Louisiana (34)
Maine (85)
Maryland (1444)
Massachusetts (8519)
Michigan (342)
Minnesota (645)
Mississippi (7)
Missouri (142)
Montana (26)
Nebraska (28)
Nevada (132)
New Hampshire (81)
New Jersey (3170)
New Mexico (24)
New York (3058)
North Carolina (1583)
North Dakota (9)
Northern California (5774)
Ohio (344)
Oklahoma (22)
Oregon (43)
Pennsylvania (2313)
Puerto Rico (23)
Rhode Island (43)
South America (1296)
South Carolina (70)
South Dakota (1)
Southern California (4550)
Tennessee (185)
Texas (1753)
United States (41675)
Utah (339)
Vermont (1)
Virginia (284)
Washington D.C. (85)
Washington State (964)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
696,254 Results for "counsyl now myriad women s health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Havah Therapeutics to Present at the RiseUp For Breast Cancer and Women’s Health Conference
February 19, 2026
·
2 min read
Press Releases
MediKarma Acquires Nanell from Niterra Co., Ltd. to Accelerate Women’s Health Expansion and Value-Based Care Footprint
February 23, 2026
·
3 min read
Press Releases
Landmark Global Study on Ovarian Cancer Published in The Lancet Obstetrics, Gynaecology, & Women’s Health
December 12, 2025
·
5 min read
Press Releases
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
February 24, 2026
·
6 min read
FDA
FDA’s One Trial Policy Not a Revolution but a Potentially Risky Evolution
Last week, the FDA made its one pivotal trial policy official, sparking myriad questions from industry leaders, including around specific evidence required for the single study and why it hasn’t been implemented across all therapeutic areas before now.
February 26, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
November 26, 2025
·
5 min read
Press Releases
Marius Pharmaceuticals Leads Effort to Redefine Women’s Health Through Testosterone Research
November 5, 2025
·
4 min read
Press Releases
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
November 10, 2025
·
4 min read
Press Releases
Historic First in Women’s Sexual Health: FDA Grants Approval for Addyi® (flibanserin) in Postmenopausal Women
December 16, 2025
·
9 min read
Business
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health
Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the appointment of Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor to its women’s health business unit, effective immediately.
February 15, 2024
·
3 min read
1 of 69,626
Next
